Source:http://linkedlifedata.com/resource/pubmed/id/21621846
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007600,
umls-concept:C0021027,
umls-concept:C0024880,
umls-concept:C0026249,
umls-concept:C0026682,
umls-concept:C0031727,
umls-concept:C0033684,
umls-concept:C0039194,
umls-concept:C0040649,
umls-concept:C0086418,
umls-concept:C0442805,
umls-concept:C0752313,
umls-concept:C1425514,
umls-concept:C1879547
|
pubmed:issue |
15-16
|
pubmed:dateCreated |
2011-8-29
|
pubmed:abstractText |
The immune regulatory molecule T cell immunoglobulin mucin domain (TIM-3) is expressed in activated T cells and in mast cells treated with transforming growth factor (TGF)-?, but underlying mechanisms for induction of TIM-3 transcription have not been well-explored. We studied the role of mitogen-activated protein kinase (MAPK) in TIM-3 transcription on the basis of the involvement of MAPK in T cell activation and TGF-? signaling. Inhibitors of MAPK-Erk kinase (MEK) as well as p38 suppressed TIM-3 transcription in phorbol myristic acid (PMA)-stimulated T cells, but inhibitors of c-Jun NH2-terminal kinase (JNK) did not. MEK over-expression enhanced TIM-3 transcription in PMA-stimulated T cells. Furthermore, -1.5kb TIM-3 promoter was activated by PMA stimulation and repressed by MEK inhibitors in Jurkat T cells. Similarly, MEK activation enhanced TIM-3 transcription in TGF-?-stimulated HMC-1 human mast cells, although MEK seemed not directly activated by TGF-?. Concordantly, -1.5kb TIM-3 promoter activity was reduced by MEK inhibitors, but was not responsive to TGF-? stimulation in HMC-1 cells. These results suggest the regulatory role of MEK in TIM-3 transcription by human CD4+ T cells and mast cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1872-9142
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1778-83
|
pubmed:meshHeading |
pubmed-meshheading:21621846-Blotting, Western,
pubmed-meshheading:21621846-CD4-Positive T-Lymphocytes,
pubmed-meshheading:21621846-Cell Line,
pubmed-meshheading:21621846-Enzyme Activation,
pubmed-meshheading:21621846-Gene Expression,
pubmed-meshheading:21621846-Gene Expression Regulation,
pubmed-meshheading:21621846-Humans,
pubmed-meshheading:21621846-Lymphocyte Activation,
pubmed-meshheading:21621846-MAP Kinase Kinase 1,
pubmed-meshheading:21621846-Mast Cells,
pubmed-meshheading:21621846-Membrane Proteins,
pubmed-meshheading:21621846-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21621846-Transcription, Genetic
|
pubmed:year |
2011
|
pubmed:articleTitle |
Activation of mitogen activated protein kinase-Erk kinase (MEK) increases T cell immunoglobulin mucin domain-3 (TIM-3) transcription in human T lymphocytes and a human mast cell line.
|
pubmed:affiliation |
Department of Microbiology, Ajou University School of Medicine, Youngtongku Wonchondong San 5, Suwon 442-749, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|